Akari Therapeutics, Plc Posts Approximately $4.8 Million Q3 Net Loss

John Kim

1 min read

Add as a preferred source on Google

Akari Therapeutics, Plc Posts Approximately $4.8 Million Q3 Net Loss

The company’s third-quarter results cover the three months ended Sept. 30, 2026.

By John Kim

Published Nov 13, 2026, 2:20 PM EST

An unmarked report page rests beneath a dark metal weight / TokenPost.ai

Akari Therapeutics, Plc (NASDAQ: AKTX) recorded an approximately $4.8 million net loss in its third-quarter 2026 financial results for the three months ended Sept. 30.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.